Lung Cancer Oncology Business Lead: Launch & Strategy

GSK; Hong Kong; In loco; HKD 1.200.000 - 1.800.000; Tempo pieno

Descrizione del lavoro

GSK in Hong Kong is seeking a senior commercial leader to manage a lung cancer precision oncology portfolio from pre-launch through launch and into market performance. You will align global strategies with local needs, collaborate with Regulatory, Market Access, Medical and Supply Chain to shape plans, monitor performance, and mitigate risks for sustained patient impact.

This role requires strong leadership in a highly matrixed environment and a deep commitment to advancing oncology therapies in

Competenze

• Develop and maintain a clear business strategy and roadmap for oncology assets from pre-launch to post-launch.
• Translate global/ regional asset strategies into practical commercial plans with KPIs and targets.
• Ability to connect scientific, commercial, and operational considerations into clear business decisions.

Mansioni

• Lead asset & portfolio strategy from pre-launch to post-launch.
• Coordinate launch readiness with Regulatory, Market Access, Medical, and Supply Chain.
• Act as central point between GSK and external partners; manage inquiries and align resources.
• Track asset performance and provide leadership with insights and risk mitigation options.
• Escalate material risks to governance forums and support mitigation planning.

Conoscenze

Strategy development

Cross-functional leadership

Launch planning

Data analytics

Stakeholder engagement

Formazione

University degree (Business/Life Sciences/Pharmacy)

Descrizione del lavoro

GSK in Hong Kong is seeking a senior commercial leader to manage a lung cancer precision oncology portfolio from pre-launch through launch and into market performance. You will align global strategies with local needs, collaborate with Regulatory, Market Access, Medical and Supply Chain to shape plans, monitor performance, and mitigate risks for sustained patient impact.

This role requires strong leadership in a highly matrixed environment and a deep commitment to advancing oncology therapies in